{
    "2018-04-20": [
        [
            {
                "time": "",
                "original_text": "金域医学上市首年业绩增速放缓 布局基因检测谋求突破行业天花板",
                "features": {
                    "keywords": [
                        "金域医学",
                        "上市首年",
                        "业绩增速放缓",
                        "基因检测",
                        "行业天花板"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]金域医学(603882)年报点评：从专注于检验服务到布局全产业链 未来业绩可期",
                "features": {
                    "keywords": [
                        "金域医学",
                        "年报",
                        "检验服务",
                        "全产业链",
                        "未来业绩可期"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}